During the past decade, Cherry Tree Cancer Center conducted 57 clinical trials. In the 10-year time frame, 57 clinical trials started and 49 clinical trials were completed, i.e. on average, 86% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 32 clinical trials were completed. i.e. 139.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cherry Tree Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 40 trials, followed by "SWOG Cancer Research Network" with 17 trials sponsored, "Alliance for Clinical Trials in Oncology" with 13 trials sponsored, "Radiation Therapy Oncology Group" with 12 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 12 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cherry Tree Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 60 trials as a collaborator, "NRG Oncology" with 23 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Radiation Therapy Oncology Group" with 2 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Cherry Tree Cancer Center" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Lung Cancer AJCC v8" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Stage IVA Lung Cancer AJCC v8" (6 trials) and "Stage IVB Lung Cancer AJCC v8" (6 trials). Many other conditions were trialed in "Cherry Tree Cancer Center" in a lesser frequency.

Most popular intervention types in "Cherry Tree Cancer Center" are "Drug" (81 trials), "Other" (67 trials), "Biological" (42 trials), "Procedure" (26 trials) and "Radiation" (20 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (36 trials), "Quality-of-Life Assessment" (25 trials), "Questionnaire Administration" (15 trials), "Paclitaxel" (14 trials) and "Biospecimen Collection" (13 trials). Other intervention names were less common.

The vast majority of trials in "Cherry Tree Cancer Center" are 78 trials for "All" genders, 17 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Cherry Tree Cancer Center". undefined are not yet recruiting, 16 are recruiting, 53 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Cherry Tree Cancer Center, 2 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Cherry Tree Cancer Center, 1 "Phase 1" clinical trials were conducted, 42 "Phase 2" clinical trials and 63 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".